Loading...

Intellectia LogoIntellectia
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. SURI
SURI logo

SURI Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • AI Stock Picker
  • Swing Trading
  • SwingMax Portfolio
  • QuantAI Alpha Pick
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • Financial AI Agent
  • AI Screener
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
17.350
Open
17.300
VWAP
17.29
Vol
2.30K
Mkt Cap
--
Low
17.256
Amount
39.84K
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Events Timeline

No data

No data

News

Benzinga
2.0
2025-11-26Benzinga
Healthcare ETFs Outperform Tech, Attract Billions as Investors Exit Due to Bubble Concerns
  • Healthcare Sector Rotation: A significant shift towards healthcare investments is occurring globally, with investors favoring sector ETFs, particularly in biotech and pharma, driven by strong performance in clinical trials and AI advancements.

  • Impact of Eli Lilly: Eli Lilly's recent achievement of a $1 trillion market cap has sparked enthusiasm in the healthcare sector, with its innovative products leading to substantial revenue growth and reshaping market expectations.

  • AI Integration in Healthcare: The integration of AI in healthcare is proving beneficial, with major companies like Lilly and Johnson & Johnson leveraging AI technologies to enhance drug discovery and surgical procedures, attracting investor interest in healthcare ETFs.

  • Sustained Investor Interest: The current healthcare investment trend reflects a recalibration rather than a temporary safety trade, as the sector combines defensiveness, innovation, and strong earnings momentum, making healthcare ETFs the primary beneficiaries.

NASDAQ.COM
4.5
2025-11-25NASDAQ.COM
Zacks Analyst Blog Features LLY, EPHE, BBC, HELX, XHS, and SURI
  • Market Overview: The stock market experienced a downturn last week, with the S&P 500, Dow Jones, and Nasdaq Composite all declining due to overvaluation concerns in the AI sector, despite NVIDIA's strong earnings report.

  • NVIDIA's Performance: NVIDIA reported a significant revenue increase of 62% year-over-year, driven by high demand for its AI data center chips, leading to an earnings per share of $1.30, surpassing expectations.

  • Eli Lilly's Milestone: Eli Lilly became the first healthcare company to reach a $1 trillion market cap, fueled by strong sales growth from its GLP-1/GIP drugs, Mounjaro and Zepbound, which contributed to a 36% stock surge this year.

  • Top-Performing ETFs: Several ETFs, including the iShares MSCI Philippines ETF and Virtus LifeSci Biotech Clinical Trials ETF, showed strong performance last week, reflecting investor interest in healthcare and biotech sectors amidst market volatility.

Benzinga
4.5
2025-02-03Benzinga
ETFs Resilient As Markets Face Volatility: Top 5 ETFs With Best Gains From Last Week Amid Macro Shifts
  • Market Performance Overview: The U.S. markets experienced volatility in the week ending January 31, with strong earnings from major companies like Meta and Apple helping to stabilize stocks, despite the S&P 500 closing 1% lower and the Nasdaq Composite declining by 1.6%.

  • ETFs Highlighted: Several ETFs showed notable weekly gains, including the Amplify Commodity Trust Breakwave Dry Bulk Shipping ETF (12.26%), Simplify Propel Opportunities ETF (8.27%), and YieldMax BABA Option Income Strategy ETF (7.38%), reflecting positive trends in sectors such as technology and healthcare.

Newsfilter
8.0
2024-11-27Newsfilter
Simplify Provides Estimated Capital Gain Distribution Information for 2024
  • Capital Gains Distributions Announcement: Simplify Asset Management Inc. is set to deliver capital gains distributions for six of its ETFs, with the ex-date and record date on December 23, 2024, and the payable date on December 31, 2024.

  • Estimated Distribution Details: The estimated capital gains per share vary among the funds, with some showing no gains while others like the Simplify Tara India Opportunities ETF and Simplify US Equity PLUS QIS ETF have significant projected gains.

NASDAQ.COM
4.5
2024-09-24NASDAQ.COM
Best-Performing ETFs of Last Week
  • Market Performance: Last week, Wall Street saw moderate gains with the S&P 500 up 1.4%, Dow Jones up 1.6%, and Nasdaq Composite up 1.5%. The Federal Reserve cut interest rates for the first time in four years, responding to cooling inflation and a slowing labor market.

  • Top-Performing ETFs: Notable ETFs included Teucrium Sugar Fund (up 13.1%), Simplify Propel Opportunities ETF (up 9.0%), Range Nuclear Renaissance Index ETF (up 8.8%), and ProShares Ultra Ether ETF (up 8.6%), reflecting strong performance in sectors like sugar, biotech, nuclear energy, and cryptocurrency.

Wall Street analysts forecast SURI stock price to rise
0 Analyst Rating
Wall Street analysts forecast SURI stock price to rise
0 Buy
0 Hold
0 Sell
Current: 0.000
sliders
Low
Averages
High
Current: 0.000
sliders
Low
Averages
High
No data

No data

Valuation Metrics

The current forward P/E ratio for (SURI) is --, compared to its 5-year average forward P/E of --. For a more detailed relative valuation and DCF analysis to assess 's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
Current PE
NaN
Overvalued PE
Undervalued PE

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
Current EV/EBITDA
NaN
Overvalued EV/EBITDA
Undervalued EV/EBITDA

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
Current PS
NaN
Overvalued PS
Undervalued PS

Financials

AI Analysis
Annual
Quarterly

Whales Holding SURI

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is (SURI) stock price today?

The current price of SURI is 17.2656 USD — it has increased 1.42

What is (SURI)'s business?

What is the price predicton of SURI Stock?

Wall Street analysts forecast SURI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SURI is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is (SURI)'s revenue for the last quarter?

revenue for the last quarter amounts to NaN USD, decreased

What is (SURI)'s earnings per share (EPS) for the last quarter?

. EPS for the last quarter amounts to USD, decreased

How many employees does (SURI). have?

(SURI) has 0 emplpoyees as of March 05 2026.

What is (SURI) market cap?

Today SURI has the market capitalization of 0.00 USD.